APA (7th ed.) Citation

Oprean, C. M., Badau, L. M., Petrita, R., Median, M. D., & Dema, A. Real-World, National Study of Palbociclib in HR+/HER2− Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021. MDPI AG.

Chicago Style (17th ed.) Citation

Oprean, Cristina Marinela, Larisa Maria Badau, Ramona Petrita, Mircea Dragos Median, and Alis Dema. Real-World, National Study of Palbociclib in HR+/HER2− Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021. MDPI AG.

MLA (9th ed.) Citation

Oprean, Cristina Marinela, et al. Real-World, National Study of Palbociclib in HR+/HER2− Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021. MDPI AG.